Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results
Go back to Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results| GLOBUS MEDICAL, Inc. (NYSE: GMED) | Delayed: 80.48 -0.89 (1.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $81.37 | 52 Week High | $28.60 | |||
| Open | $81.46 | 52 Week Low | $19.25 | |||
| Day High | $82.89 | P/E | 110.25 | |||
| Day Low | $79.69 | EPS | $0.73 | |||
| Volume | 1,054,387 | |||||
| (NYSE: NVRO) | Delayed: 5.84 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.84 | 52 Week High | $106.93 | |||
| Open | $5.84 | 52 Week Low | $47.07 | |||
| Day High | $5.84 | P/E | N/A | |||
| Day Low | $5.84 | EPS | $0.00 | |||
| Volume | 14 | |||||
